Skip to main content
XXII
NASDAQ Life Sciences

French Health Agency Backs Nicotine Caps, Citing 22nd Century's Tech as Only Commercial Path

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Industrial
Sentiment info
Positive
Importance info
7
Price
$1.388
Mkt Cap
$949.612K
52W Low
$1.15
52W High
$646.5
52W Position info
21% above low
Off High info
100% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

XXII sits 21% above its 52-week low of $1.15 on elevated volume (2.3× avg).

Summary

France's ANSES recommends a maximum nicotine limit for all combustible tobacco, explicitly naming 22nd Century's reduced-nicotine tobacco as the only commercially available production path. The company has expanded its platform to include non-GMO tobacco, removing a key regulatory barrier for EU adoption. This follows a difficult year: Q2 revenue fell 30% to $2.9M with going concern doubts, and the stock trades near $1.39 after a June reverse split. The French market alone is estimated at over €20B annually, with a sustainable legal market of €8-13B post-regulation. EU legislative proposals are expected before end of 2026, creating a potential multi-billion-euro opportunity if the company can scale supply.

At the time of this announcement, XXII was trading at $1.39 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $949.6K. The 52-week trading range was $1.15 to $646.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

XXII - Latest Insights

XXII
Nov 16, 2026, 6:31 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.7208
Real-time Price: $0.402799 info
Change: -$0.318001 (-44%) info
Market Cap: $222.987K info
XXII
Nov 16, 2026, 6:02 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.690
Real-time Price: $0.402799 info
Change: -$0.287201 (-42%) info
Market Cap: $222.987K info
XXII
Nov 16, 2026, 6:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.7101
Real-time Price: $0.402799 info
Change: -$0.307301 (-43%) info
Market Cap: $222.987K info
XXII
Nov 03, 2026, 12:35 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.0565
Real-time Price: $0.402799 info
Change: Reverse Stock Split info
Market Cap: $222.987K info
XXII
Nov 03, 2026, 11:40 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.06355
Real-time Price: $0.402799 info
Change: Reverse Stock Split info
Market Cap: $222.987K info